Raymond I Huang, MD
Cardiovascular Disease (Cardiology) · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 23
- 5 carriers
- Office
- 1
Offices
1 location
Hospitals listed: El Camino Health · Good Samaritan Hospital. That is not proof they admit you there this week.
Plans that list them
23 plans · 5 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Huang’s office at (408) 356-8784 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
23 of 23 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
California Medical Board record
Licence A70992 · Current
Licensed to practise in California · since 2000 · expires 2027-11-30 · University of Southern California Keck School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$164,374
Medicare paid this office $164,374 for 559 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 244 | $61,591 | $117 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 87 | $17,059 | $190 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 61 | $16,297 | $106 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 77 | $12,256 | $153 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 22 | $10,291 | $468 |
See all 19 services
| Return visit (30+ min) | 244 | $61,591 | $117 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 87 | $17,059 | $190 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 61 | $16,297 | $106 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 77 | $12,256 | $153 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 22 | $10,291 | $468 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 14 | $7,487 | $440 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 91 | $5,784 | $62 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 229 | $5,182 | $14 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 22 | $4,398 | $100 |
| Short return visit (20+ min) | 46 | $4,333 | $88 |
| New patient visit (45+ min) | 29 | $4,313 | $149 |
| Programming of dual lead pacemaker system | 25 | $3,269 | $74 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 44 | $3,091 | $66 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 13 | $2,570 | $171 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 15 | $1,262 | $79 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 161 | $1,083 | $6 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 11 | $789 | $72 |
| Injection, regadenoson, 0.1 mg | 11 | $206 | None |
| Infusion, normal saline solution, 250 cc | 22 | $11 | None |
Procedures Medicare counted
| Coronary angioplasty and stenting | 22 | More than 52% of doctors who do this |
Who their Medicare patients are
559 Original Medicare patients in 2024. Average age 80 · Under 65 2% · 85 and older 29% · Women 46% · Also on Medicaid 16% · Health risk score 1.57. At or below the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Coronary heart disease 47% · Diabetes 36% · Atrial fibrillation 35% · Chronic kidney disease 34% · Heart failure 28% · Cancer 19% · Depression 19% · Dementia 18% · Stroke 17% · COPD 16%.
The office billed $437,888, Medicare allowed $211,788 and paid $164,374; for 1,945 services of 38 kinds; $285 of it was for drugs given in the office and $164,088 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 559 | 1,945 | 80 | 1.57 | $437,888 | $164,374 |
| 2023 | 544 | 1,923 | 79 | 1.56 | $437,177 | $156,402 |
| 2022 | 624 | 2,157 | 79 | 1.45 | $487,001 | $179,584 |
| 2021 | 565 | 2,165 | 79 | 1.41 | $504,933 | $185,259 |
| 2020 | 549 | 2,163 | 78 | 1.56 | $540,237 | $185,306 |
| 2019 | 782 | 2,848 | 78 | 1.59 | $712,173 | $234,602 |
| 2018 | 764 | 2,990 | 77 | 1.55 | $754,198 | $249,506 |
| 2017 | 532 | 2,017 | 78 | 1.65 | $517,839 | $165,292 |
| 2016 | 507 | 2,000 | 77 | 1.55 | $517,241 | $174,754 |
| 2015 | 463 | 2,073 | 77 | 1.54 | $579,515 | $198,696 |
| 2014 | 382 | 1,535 | 77 | 1.55 | $452,324 | $153,082 |
| 2013 | 406 | 1,769 | 78 | 1.45 | $544,084 | $178,563 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 17 services
| Return visit (30+ min) | 251 | $50,120 | $104 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 56 | $18,445 | $104 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 87 | $16,553 | $190 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 31 | $14,284 | $461 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 52 | $8,531 | $142 |
| New patient visit (45+ min) | 46 | $6,860 | $149 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 31 | $6,198 | $100 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 11 | $5,451 | $454 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 84 | $4,953 | $58 |
| Short return visit (20+ min) | 52 | $4,799 | $77 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 238 | $4,669 | $12 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 47 | $3,292 | $65 |
| Programming of dual lead pacemaker system | 23 | $2,874 | $68 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 156 | $1,200 | $7 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 15 | $982 | $65 |
| Infusion, normal saline solution, 250 cc | 31 | $15 | None |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 13 | $9 | None |
2022: 20 services
| Return visit (30+ min) | 266 | $63,805 | $112 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 94 | $18,370 | $189 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 32 | $15,187 | $475 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 63 | $13,673 | $89 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 69 | $13,304 | $171 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 17 | $8,245 | $485 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 31 | $6,244 | $101 |
| New patient visit (45+ min) | 38 | $5,586 | $147 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 83 | $5,305 | $61 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 244 | $5,253 | $13 |
| Short return visit (20+ min) | 58 | $4,983 | $80 |
| Programming of dual lead pacemaker system | 30 | $4,118 | $76 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 46 | $3,835 | $66 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 14 | $2,693 | $192 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 227 | $1,733 | $7 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 15 | $1,161 | $73 |
| Ultrasonic guidance for blood vessel access | 15 | $189 | $12 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 15 | $170 | $11 |
| Infusion, normal saline solution, 250 cc | 32 | $16 | None |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 14 | $8 | None |
2021: 23 services
| Return visit (30+ min) | 273 | $58,184 | $109 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 106 | $21,975 | $202 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 35 | $17,413 | $498 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 52 | $12,746 | $91 |
| Short return visit (20+ min) | 120 | $11,841 | $81 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 22 | $11,805 | $472 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 57 | $10,819 | $175 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 35 | $6,634 | $95 |
| New patient visit (45+ min) | 39 | $5,355 | $137 |
| Programming of dual lead pacemaker system | 36 | $5,071 | $75 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 258 | $4,924 | $13 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 68 | $4,448 | $63 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 60 | $4,187 | $68 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 13 | $2,242 | $172 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 147 | $1,282 | $8 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 23 | $507 | $22 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 23 | $363 | $16 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 14 | $253 | $18 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 22 | $252 | $11 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 14 | $170 | $12 |
| Ultrasonic guidance for blood vessel access | 14 | $169 | $12 |
| Infusion, normal saline solution, 250 cc | 34 | $18 | None |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 20 | $16 | None |
2020: 24 services
| Return visit (30+ min) | 279 | $46,360 | $94 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 116 | $22,966 | $195 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 61 | $16,319 | $92 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 33 | $16,157 | $490 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 20 | $12,926 | $462 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 64 | $12,362 | $177 |
| Short return visit (20+ min) | 133 | $9,982 | $62 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 33 | $6,158 | $93 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 76 | $5,510 | $65 |
| New patient visit (45+ min) | 37 | $5,070 | $137 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 242 | $5,053 | $15 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 24 | $4,625 | $178 |
| Programming of dual lead pacemaker system | 34 | $4,287 | $63 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 59 | $4,215 | $63 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 20 | $1,546 | $74 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 123 | $1,018 | $8 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 12 | $970 | $81 |
| Ultrasonic guidance for blood vessel access | 26 | $342 | $13 |
| Online digital evaluation and management service for an established patient for up to 7 days, total time 11-20 minutes | 11 | $328 | $27 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 16 | $316 | $20 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 22 | $247 | $11 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 16 | $212 | $13 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 19 | $16 | None |
| Infusion, normal saline solution, 250 cc | 33 | $16 | None |
2019: 25 services
| Return visit (30+ min) | 303 | $48,123 | $88 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 148 | $29,977 | $195 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 60 | $28,994 | $483 |
| Short return visit (20+ min) | 240 | $19,988 | $58 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 77 | $16,314 | $89 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 61 | $11,822 | $169 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 20 | $11,271 | $451 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 60 | $10,990 | $92 |
| New patient visit (45+ min) | 64 | $7,697 | $120 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 33 | $7,219 | $219 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 89 | $6,413 | $63 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 96 | $6,269 | $63 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 227 | $4,608 | $15 |
| Programming of dual lead pacemaker system | 40 | $4,004 | $55 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 18 | $1,946 | $108 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 227 | $1,725 | $7 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 17 | $1,447 | $80 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 14 | $1,056 | $75 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 33 | $661 | $19 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 33 | $444 | $13 |
| Ultrasonic guidance for blood vessel access | 26 | $323 | $12 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 16 | $180 | $11 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 14 | $65 | $5 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 45 | $47 | None |
| Infusion, normal saline solution, 250 cc | 60 | $28 | None |
2018: 23 services
| Return visit (30+ min) | 258 | $38,085 | $91 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 181 | $35,334 | $191 |
| Short return visit (20+ min) | 280 | $25,326 | $59 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 48 | $23,985 | $489 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 95 | $21,696 | $88 |
| New patient visit (45+ min) | 111 | $14,542 | $131 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 65 | $13,457 | $170 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 24 | $12,354 | $441 |
| New patient visit (30+ min) | 112 | $9,838 | $88 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 48 | $8,883 | $91 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 329 | $6,848 | $15 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 88 | $6,621 | $65 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 93 | $6,088 | $63 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 29 | $5,054 | $174 |
| Programming of dual lead pacemaker system | 47 | $4,058 | $51 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 34 | $2,678 | $77 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 20 | $1,520 | $76 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 120 | $934 | $7 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 34 | $388 | $10 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 11 | $248 | $19 |
| Ultrasonic guidance for blood vessel access | 12 | $146 | $12 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 25 | $30 | None |
| Infusion, normal saline solution, 250 cc | 48 | $23 | None |
2017: 20 services
| Short return visit (20+ min) | 220 | $28,414 | $58 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 107 | $22,133 | $201 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 43 | $19,600 | $456 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 70 | $16,205 | $84 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 57 | $10,164 | $161 |
| Return visit (30+ min) | 87 | $9,542 | $84 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 18 | $9,335 | $424 |
| New patient visit (45+ min) | 73 | $8,625 | $118 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 43 | $7,516 | $87 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 26 | $5,279 | $189 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 66 | $3,587 | $51 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 167 | $3,253 | $14 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 43 | $2,759 | $60 |
| Programming of dual lead pacemaker system | 20 | $1,938 | $50 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 21 | $1,572 | $71 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 151 | $1,225 | $7 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 15 | $1,131 | $75 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 26 | $279 | $10 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 20 | $18 | None |
| Infusion, normal saline solution, 250 cc | 43 | $17 | None |
2016: 20 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 95 | $27,236 | $88 |
| Short return visit (20+ min) | 226 | $25,845 | $57 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 89 | $19,053 | $207 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 32 | $14,878 | $465 |
| Return visit (30+ min) | 113 | $14,231 | $87 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 72 | $13,455 | $166 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 17 | $10,446 | $454 |
| New patient visit (45+ min) | 70 | $8,902 | $127 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 32 | $5,801 | $91 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 87 | $5,063 | $54 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 21 | $4,342 | $189 |
| Critical care, first 30-74 minutes | 14 | $3,160 | $186 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 158 | $3,013 | $14 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 37 | $2,401 | $63 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 26 | $2,000 | $74 |
| Programming of dual lead pacemaker system | 19 | $1,473 | $51 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 14 | $1,334 | $78 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 98 | $622 | $6 |
| Infusion, normal saline solution, 250 cc | 32 | $11 | None |
| Injection, dipyridamole, per 10 mg | 15 | $9 | None |
2015: 23 services
| Short return visit (20+ min) | 212 | $27,273 | $59 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 94 | $25,558 | $88 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 121 | $25,294 | $202 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 31 | $14,773 | $477 |
| Return visit (30+ min) | 108 | $14,672 | $90 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 75 | $13,480 | $164 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 21 | $12,890 | $430 |
| New patient visit (45+ min) | 86 | $10,342 | $120 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 31 | $7,777 | $125 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 35 | $7,523 | $193 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 70 | $4,134 | $54 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 46 | $3,187 | $64 |
| Critical care, first 30-74 minutes | 15 | $3,171 | $187 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 140 | $2,991 | $15 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 35 | $2,722 | $74 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 21 | $1,740 | $79 |
| Programming of dual lead pacemaker system | 17 | $1,705 | $49 |
| Hospital discharge day management, 30 minutes or less | 16 | $1,071 | $63 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 63 | $531 | $8 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 14 | $267 | $19 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 14 | $174 | $12 |
| Injection, dipyridamole, per 10 mg | 17 | $10 | None |
| Infusion, normal saline solution, 250 cc | 31 | $9 | None |
2014: 21 services
| Short return visit (20+ min) | 184 | $23,924 | $59 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 25 | $14,864 | $425 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 69 | $14,576 | $88 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 58 | $12,010 | $207 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 69 | $11,942 | $166 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 24 | $11,291 | $470 |
| Return visit (30+ min) | 72 | $9,437 | $84 |
| New patient visit (45+ min) | 71 | $9,070 | $128 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 29 | $6,279 | $196 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 24 | $6,011 | $125 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 64 | $3,349 | $52 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 34 | $2,288 | $64 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 110 | $1,929 | $14 |
| Programming of dual lead pacemaker system | 14 | $1,366 | $49 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 17 | $1,287 | $76 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 13 | $1,058 | $76 |
| Hospital discharge day management, 30 minutes or less | 14 | $933 | $62 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 13 | $245 | $19 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 13 | $161 | $12 |
| Injection, dipyridamole, per 10 mg | 13 | $8 | None |
| Infusion, normal saline solution, 250 cc | 24 | $6 | None |
2013: 23 services
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 43 | $26,418 | $406 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 114 | $26,108 | $85 |
| Short return visit (20+ min) | 175 | $21,924 | $58 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 32 | $15,589 | $487 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 86 | $14,986 | $163 |
| Return visit (30+ min) | 82 | $11,913 | $90 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 63 | $11,003 | $169 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 32 | $7,936 | $126 |
| New patient visit (45+ min) | 46 | $6,038 | $131 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 27 | $5,014 | $152 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 80 | $4,421 | $53 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 39 | $2,538 | $65 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 103 | $2,086 | $16 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 21 | $1,698 | $81 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 13 | $1,102 | $73 |
| Programming of dual lead pacemaker system | 14 | $973 | $46 |
| Hospital discharge day management, 30 minutes or less | 13 | $852 | $61 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $778 | $60 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 28 | $243 | $7 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 12 | $219 | $18 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 12 | $158 | $12 |
| Injection, dipyridamole, per 10 mg | 18 | $12 | None |
| Infusion, normal saline solution, 250 cc | 27 | $6 | None |
Medicaid work
$288 in 2024
Medicaid paid $288 for 79 billed services this clinician did in 2024, up to 28 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 79 | $288 |
| 2024 | 79 | 1 | 28 | $288 |
| 2023 | 63 | 2 | 18 | $504 |
| 2022 | 84 | 2 | 21 | $530 |
| 2021 | 53 | 1 | 22 | $233 |
| 2020 | 26 | 1 | 13 | $86 |
| 2019 | 69 | 1 | 19 | $316 |
| 2018 | 27 | 1 | 15 | $151 |
See the largest Medicaid services in earlier years
2023
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 12 | $260 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 51 | $245 |
2022
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 12 | $291 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 72 | $240 |
2021
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 53 | $233 |
2020
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 26 | $86 |
2019
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 69 | $316 |
2018
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 27 | $151 |
Drugs they prescribed that Part D paid
$410,760
Pharmacies billed $410,760 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 2,493) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
2,133 generic and 360 brand-name prescriptions · $410,760 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 203 | $285,158 | $1,405 |
| Xarelto | 44 | $54,116 | $1,230 |
| Repatha | 17 | $13,769 | $810 |
| Repatha Sureclick | 14 | $7,798 | $557 |
| Atorvastatin | 248 | $3,054 | $12 |
See all 40 drugs
| Eliquis | 203 | $285,158 | $1,405 |
| Xarelto | 44 | $54,116 | $1,230 |
| Repatha | 17 | $13,769 | $810 |
| Repatha Sureclick | 14 | $7,798 | $557 |
| Atorvastatin | 248 | $3,054 | $12 |
| Amlodipine Besylate | 359 | $2,501 | $7 |
| Metoprolol | 141 | $2,139 | $15 |
| Diltiazem 24hr Er (Cd) | 35 | $1,671 | $48 |
| Losartan | 158 | $1,597 | $10 |
| Metoprolol | 104 | $1,421 | $14 |
| Flecainide Acetate | 30 | $1,415 | $47 |
| Lisinopril | 105 | $1,134 | $11 |
| Rosuvastatin | 65 | $1,096 | $17 |
| Carvedilol | 90 | $1,083 | $12 |
| Clopidogrel | 33 | $887 | $27 |
| Valsartan | 19 | $828 | $44 |
| Chlorthalidone | 45 | $809 | $18 |
| Diltiazem 24hr Er (Xr) | 20 | $801 | $40 |
| Amiodarone | 30 | $786 | $26 |
| Nebivolol | 15 | $640 | $43 |
| Doxazosin Mesylate | 49 | $633 | $13 |
| Furosemide | 118 | $603 | $5 |
| Isosorbide Dinitrate | 18 | $589 | $33 |
| Isosorbide Mononitrate | 20 | $564 | $28 |
| Diltiazem 24hr Er | 12 | $558 | $46 |
| Valsartan-Hydrochlorothiazide | 16 | $508 | $32 |
| Isosorbide Mononitrate Er | 25 | $441 | $18 |
| Enalapril Maleate | 16 | $418 | $26 |
| Hydralazine | 27 | $376 | $14 |
| Simvastatin | 17 | $359 | $21 |
| Spironolactone | 36 | $353 | $10 |
| Atenolol | 30 | $306 | $10 |
| Verapamil Er | 11 | $297 | $27 |
| Nitroglycerin | 33 | $268 | $8 |
| Triamterene-Hydrochlorothiazid | 23 | $256 | $11 |
| Hydrochlorothiazide | 25 | $172 | $7 |
| Ramipril | 12 | $157 | $13 |
| Clonidine | 11 | $102 | $9 |
| Warfarin | 15 | $88 | $6 |
| Benazepril | 12 | $6 | $1 |
Year by year
| 2024 | 2,493 | 263 | 0% (0) | 14% | $410,760 |
| 2023 | 2,334 | 277 | 0% (0) | 14% | $428,344 |
| 2022 | 2,654 | 272 | 0% (0) | 15% | $463,604 |
| 2021 | 2,988 | 304 | 0% (0) | None | $506,748 |
| 2020 | 3,566 | 329 | None | 20% | $560,776 |
| 2019 | 4,307 | 390 | 0% (0) | None | $505,982 |
| 2018 | 4,155 | 402 | 0% (0) | 16% | $369,939 |
| 2017 | 2,914 | 255 | None | 19% | $220,601 |
| 2016 | 2,670 | 246 | None | 20% | $184,180 |
| 2015 | 2,139 | 204 | 0% (0) | 23% | $132,427 |
| 2014 | 1,904 | 197 | None | 24% | $103,538 |
| 2013 | 1,590 | 169 | None | 25% | $71,695 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 39 drugs
| Eliquis | 188 | $282,465 | $1,502 |
| Xarelto | 44 | $51,402 | $1,168 |
| Repatha | 18 | $11,855 | $659 |
| Brilinta | 16 | $10,870 | $679 |
| Repatha Sureclick | 13 | $7,724 | $594 |
| Atorvastatin | 258 | $3,043 | $12 |
| Amlodipine Besylate | 307 | $2,971 | $10 |
| Diltiazem 24hr Er (Cd) | 55 | $2,943 | $54 |
| Metoprolol | 161 | $2,574 | $16 |
| Flecainide Acetate | 27 | $2,325 | $86 |
| Carvedilol | 101 | $1,966 | $19 |
| Losartan | 127 | $1,825 | $14 |
| Isosorbide Dinitrate | 21 | $1,407 | $67 |
| Metoprolol | 116 | $1,407 | $12 |
| Nebivolol | 14 | $1,353 | $97 |
| Rosuvastatin | 49 | $1,173 | $24 |
| Amiodarone | 26 | $1,143 | $44 |
| Lisinopril | 110 | $1,116 | $10 |
| Isosorbide Mononitrate Er | 27 | $1,066 | $39 |
| Nitroglycerin | 35 | $1,048 | $30 |
| Chlorthalidone | 36 | $779 | $22 |
| Potassium Chloride | 27 | $754 | $28 |
| Isosorbide Mononitrate | 15 | $668 | $45 |
| Valsartan-Hydrochlorothiazide | 12 | $637 | $53 |
| Sotalol | 17 | $629 | $37 |
| Hydralazine | 23 | $621 | $27 |
| Clopidogrel | 28 | $597 | $21 |
| Valsartan | 14 | $570 | $41 |
| Furosemide | 65 | $551 | $8 |
| Verapamil Er | 11 | $514 | $47 |
| Enalapril Maleate | 17 | $490 | $29 |
| Simvastatin | 12 | $440 | $37 |
| Atenolol | 32 | $360 | $11 |
| Doxazosin Mesylate | 17 | $340 | $20 |
| Warfarin | 37 | $333 | $9 |
| Triamterene-Hydrochlorothiazid | 14 | $272 | $19 |
| Spironolactone | 16 | $222 | $14 |
| Ramipril | 15 | $178 | $12 |
| Hydrochlorothiazide | 26 | $82 | $3 |
2022: 44 drugs
| Eliquis | 231 | $299,001 | $1,294 |
| Xarelto | 56 | $65,900 | $1,177 |
| Brilinta | 25 | $13,533 | $541 |
| Entresto | 11 | $11,619 | $1,056 |
| Repatha | 12 | $6,528 | $544 |
| Diltiazem 24hr Er (Cd) | 58 | $3,959 | $68 |
| Atorvastatin | 299 | $2,929 | $10 |
| Metoprolol | 173 | $2,797 | $16 |
| Flecainide Acetate | 34 | $2,457 | $72 |
| Carvedilol | 128 | $2,217 | $17 |
| Amlodipine Besylate | 326 | $2,036 | $6 |
| Rosuvastatin | 62 | $1,775 | $29 |
| Valsartan | 27 | $1,732 | $64 |
| Isosorbide Mononitrate Er | 37 | $1,662 | $45 |
| Ranolazine Er | 16 | $1,576 | $98 |
| Sotalol Af | 13 | $1,228 | $94 |
| Losartan | 120 | $1,178 | $10 |
| Chlorthalidone | 43 | $1,151 | $27 |
| Isosorbide Dinitrate | 16 | $1,096 | $68 |
| Metoprolol | 130 | $1,063 | $8 |
| Diltiazem 24hr Er | 12 | $1,017 | $85 |
| Isosorbide Mononitrate | 20 | $975 | $49 |
| Clopidogrel | 39 | $925 | $24 |
| Nitroglycerin | 57 | $920 | $16 |
| Digoxin | 19 | $911 | $48 |
| Amiodarone | 27 | $838 | $31 |
| Potassium Chloride | 30 | $816 | $27 |
| Lisinopril | 114 | $802 | $7 |
| Valsartan-Hydrochlorothiazide | 15 | $722 | $48 |
| Furosemide | 56 | $620 | $11 |
| Warfarin | 42 | $553 | $13 |
| Sotalol | 18 | $539 | $30 |
| Triamterene-Hydrochlorothiazid | 30 | $458 | $15 |
| Enalapril Maleate | 21 | $454 | $22 |
| Spironolactone | 31 | $421 | $14 |
| Hydralazine | 12 | $317 | $26 |
| Diltiazem 24hr Er (Xr) | 11 | $291 | $26 |
| Klor-Con 10 | 12 | $268 | $22 |
| Pravastatin | 12 | $265 | $22 |
| Atenolol | 36 | $264 | $7 |
| Doxazosin Mesylate | 16 | $240 | $15 |
| Simvastatin | 16 | $226 | $14 |
| Hydrochlorothiazide | 36 | $204 | $6 |
| Ramipril | 12 | $91 | $8 |
2021: 45 drugs
| Eliquis | 287 | $313,311 | $1,092 |
| Xarelto | 73 | $76,127 | $1,043 |
| Entresto | 21 | $28,779 | $1,370 |
| Brilinta | 12 | $6,777 | $565 |
| Repatha | 12 | $6,117 | $510 |
| Atorvastatin | 340 | $4,672 | $14 |
| Metoprolol | 187 | $4,005 | $21 |
| Diltiazem 24hr Er (Cd) | 58 | $3,926 | $68 |
| Flecainide Acetate | 32 | $3,003 | $94 |
| Amlodipine Besylate | 340 | $2,439 | $7 |
| Isosorbide Mononitrate Er | 63 | $1,992 | $32 |
| Rosuvastatin | 53 | $1,986 | $37 |
| Carvedilol | 130 | $1,844 | $14 |
| Losartan | 131 | $1,707 | $13 |
| Prasugrel | 17 | $1,372 | $81 |
| Amiodarone | 37 | $1,335 | $36 |
| Valsartan | 24 | $1,291 | $54 |
| Isosorbide Dinitrate | 13 | $1,174 | $90 |
| Digoxin | 23 | $1,160 | $50 |
| Nitroglycerin | 62 | $1,142 | $18 |
| Ranolazine Er | 15 | $1,141 | $76 |
| Lisinopril | 134 | $1,057 | $8 |
| Metoprolol | 131 | $1,006 | $8 |
| Diltiazem 24hr Er | 13 | $984 | $76 |
| Potassium Chloride | 32 | $950 | $30 |
| Chlorthalidone | 34 | $832 | $24 |
| Warfarin | 70 | $830 | $12 |
| Triamterene-Hydrochlorothiazid | 45 | $769 | $17 |
| Cartia Xt | 11 | $754 | $69 |
| Clopidogrel | 44 | $735 | $17 |
| Valsartan-Hydrochlorothiazide | 12 | $733 | $61 |
| Sotalol | 22 | $725 | $33 |
| Enalapril Maleate | 17 | $625 | $37 |
| Doxazosin Mesylate | 18 | $593 | $33 |
| Furosemide | 83 | $572 | $7 |
| Hydralazine | 23 | $466 | $20 |
| Dilt-Xr | 12 | $417 | $35 |
| Atenolol | 32 | $309 | $10 |
| Spironolactone | 28 | $307 | $11 |
| Pravastatin | 12 | $277 | $23 |
| Hydrochlorothiazide | 53 | $251 | $5 |
| Diltiazem | 11 | $215 | $20 |
| Simvastatin | 22 | $199 | $9 |
| Clonidine | 13 | $116 | $9 |
| Benazepril | 13 | $63 | $5 |
2020: 45 drugs
| Eliquis | 355 | $329,235 | $927 |
| Xarelto | 93 | $73,901 | $795 |
| Entresto | 45 | $40,799 | $907 |
| Metoprolol | 248 | $6,562 | $26 |
| Atorvastatin | 352 | $6,307 | $18 |
| Repatha | 13 | $6,212 | $478 |
| Flecainide Acetate | 60 | $4,639 | $77 |
| Diltiazem 24hr Er (Cd) | 76 | $4,163 | $55 |
| Bystolic | 16 | $3,607 | $225 |
| Digoxin | 73 | $3,427 | $47 |
| Losartan | 197 | $2,278 | $12 |
| Valsartan | 25 | $2,117 | $85 |
| Amlodipine Besylate | 278 | $1,964 | $7 |
| Valsartan-Hydrochlorothiazide | 22 | $1,840 | $84 |
| Isosorbide Mononitrate Er | 74 | $1,810 | $24 |
| Carvedilol | 141 | $1,534 | $11 |
| Ranolazine Er | 18 | $1,527 | $85 |
| Potassium Chloride | 40 | $1,505 | $38 |
| Prasugrel | 25 | $1,394 | $56 |
| Chlorthalidone | 27 | $1,269 | $47 |
| Cartia Xt | 20 | $1,252 | $63 |
| Rosuvastatin | 41 | $1,211 | $30 |
| Amiodarone | 54 | $1,122 | $21 |
| Nitroglycerin | 65 | $1,118 | $17 |
| Isosorbide Dinitrate | 21 | $1,079 | $51 |
| Lisinopril | 152 | $1,066 | $7 |
| Warfarin | 68 | $1,048 | $15 |
| Diltiazem 24hr Er | 11 | $983 | $89 |
| Metoprolol | 140 | $969 | $7 |
| Furosemide | 144 | $953 | $7 |
| Triamterene-Hydrochlorothiazid | 59 | $952 | $16 |
| Clopidogrel | 41 | $839 | $20 |
| Doxazosin Mesylate | 16 | $792 | $49 |
| Sotalol | 20 | $636 | $32 |
| Atenolol | 51 | $524 | $10 |
| Spironolactone | 52 | $493 | $9 |
| Hydrochlorothiazide | 63 | $468 | $7 |
| Enalapril Maleate | 16 | $409 | $26 |
| Hydralazine | 16 | $380 | $24 |
| Simvastatin | 31 | $298 | $10 |
| Pravastatin | 13 | $276 | $21 |
| Diltiazem | 17 | $251 | $15 |
| Lovastatin | 13 | $180 | $14 |
| Clonidine | 19 | $145 | $8 |
| Benazepril | 21 | $118 | $6 |
2019: 51 drugs
| Eliquis | 430 | $271,845 | $632 |
| Xarelto | 158 | $97,120 | $615 |
| Entresto | 23 | $13,996 | $609 |
| Metoprolol | 271 | $7,537 | $28 |
| Ranexa | 15 | $7,535 | $502 |
| Ranolazine Er | 27 | $7,494 | $278 |
| Atorvastatin | 364 | $6,934 | $19 |
| Brilinta | 16 | $5,882 | $368 |
| Diltiazem 24hr Er (Cd) | 98 | $5,670 | $58 |
| Flecainide Acetate | 69 | $4,093 | $59 |
| Digoxin | 77 | $3,749 | $49 |
| Isosorbide Dinitrate | 62 | $3,481 | $56 |
| Amlodipine Besylate | 360 | $2,705 | $8 |
| Prasugrel | 31 | $2,686 | $87 |
| Losartan | 228 | $2,384 | $10 |
| Isosorbide Mononitrate Er | 76 | $2,265 | $30 |
| Cartia Xt | 47 | $2,000 | $43 |
| Carvedilol | 146 | $1,967 | $13 |
| Amiodarone | 55 | $1,727 | $31 |
| Rosuvastatin | 36 | $1,610 | $45 |
| Nitroglycerin | 72 | $1,595 | $22 |
| Valsartan | 33 | $1,591 | $48 |
| Doxazosin Mesylate | 32 | $1,502 | $47 |
| Valsartan-Hydrochlorothiazide | 21 | $1,438 | $68 |
| Lisinopril | 170 | $1,436 | $8 |
| Furosemide | 199 | $1,432 | $7 |
| Metoprolol | 179 | $1,251 | $7 |
| Clopidogrel | 62 | $1,216 | $20 |
| Ezetimibe | 23 | $1,144 | $50 |
| Potassium Chloride | 48 | $1,081 | $23 |
| Diltiazem 24hr Er | 12 | $1,053 | $88 |
| Chlorthalidone | 33 | $1,025 | $31 |
| Digox | 26 | $1,015 | $39 |
| Warfarin | 46 | $980 | $21 |
| Triamterene-Hydrochlorothiazid | 70 | $917 | $13 |
| Sotalol | 22 | $794 | $36 |
| Enalapril Maleate | 20 | $757 | $38 |
| Hydrochlorothiazide | 82 | $650 | $8 |
| Spironolactone | 71 | $644 | $9 |
| Simvastatin | 45 | $522 | $12 |
| Atenolol | 59 | $491 | $8 |
| Diltiazem | 23 | $469 | $20 |
| Isosorbide Mononitrate | 19 | $380 | $20 |
| Pravastatin | 34 | $330 | $10 |
| Benazepril | 22 | $306 | $14 |
| Clonidine | 20 | $186 | $9 |
| Verapamil Er | 12 | $169 | $14 |
| Quinapril | 12 | $156 | $13 |
| Lovastatin | 13 | $156 | $12 |
| Verapamil | 12 | $131 | $11 |
| Hydralazine | 11 | $107 | $10 |
2018: 48 drugs
| Eliquis | 344 | $201,842 | $587 |
| Xarelto | 91 | $56,049 | $616 |
| Ranexa | 47 | $20,698 | $440 |
| Metoprolol | 308 | $8,473 | $28 |
| Atorvastatin | 365 | $7,454 | $20 |
| Diltiazem 24hr Er (Cd) | 96 | $5,510 | $57 |
| Isosorbide Dinitrate | 90 | $4,624 | $51 |
| Digoxin | 73 | $4,189 | $57 |
| Amiodarone | 61 | $3,771 | $62 |
| Flecainide Acetate | 53 | $3,484 | $66 |
| Bystolic | 13 | $3,097 | $238 |
| Amlodipine Besylate | 366 | $2,885 | $8 |
| Isosorbide Mononitrate Er | 82 | $2,287 | $28 |
| Losartan | 279 | $2,165 | $8 |
| Digox | 24 | $2,096 | $87 |
| Rosuvastatin | 42 | $2,045 | $49 |
| Clopidogrel | 115 | $1,830 | $16 |
| Prasugrel | 15 | $1,709 | $114 |
| Doxazosin Mesylate | 31 | $1,663 | $54 |
| Cartia Xt | 47 | $1,653 | $35 |
| Ezetimibe | 21 | $1,499 | $71 |
| Valsartan | 42 | $1,457 | $35 |
| Carvedilol | 162 | $1,433 | $9 |
| Lisinopril | 188 | $1,269 | $7 |
| Triamterene-Hydrochlorothiazid | 85 | $1,263 | $15 |
| Metoprolol | 204 | $1,181 | $6 |
| Potassium Chloride | 56 | $1,179 | $21 |
| Warfarin | 54 | $1,116 | $21 |
| Chlorthalidone | 32 | $1,021 | $32 |
| Valsartan-Hydrochlorothiazide | 19 | $858 | $45 |
| Spironolactone | 70 | $790 | $11 |
| Furosemide | 151 | $787 | $5 |
| Sotalol Af | 17 | $679 | $40 |
| Sotalol | 15 | $622 | $41 |
| Bumetanide | 12 | $593 | $49 |
| Nitroglycerin | 31 | $568 | $18 |
| Digitek | 16 | $486 | $30 |
| Hydrochlorothiazide | 54 | $459 | $8 |
| Atenolol | 42 | $423 | $10 |
| Simvastatin | 37 | $355 | $10 |
| Diltiazem 24hr Er | 15 | $344 | $23 |
| Verapamil | 13 | $291 | $22 |
| Hydralazine | 16 | $239 | $15 |
| Losartan-Hydrochlorothiazide | 13 | $226 | $17 |
| Cilostazol | 13 | $218 | $17 |
| Isosorbide Mononitrate | 13 | $154 | $12 |
| Clonidine | 14 | $127 | $9 |
| Benazepril | 14 | $91 | $7 |
2017: 43 drugs
| Eliquis | 252 | $124,230 | $493 |
| Effient | 36 | $16,776 | $466 |
| Ranexa | 23 | $10,899 | $474 |
| Xarelto | 26 | $10,159 | $391 |
| Metoprolol | 238 | $5,820 | $24 |
| Atorvastatin | 301 | $4,587 | $15 |
| Isosorbide Dinitrate | 73 | $3,755 | $51 |
| Bystolic | 12 | $2,094 | $175 |
| Amlodipine Besylate | 307 | $1,819 | $6 |
| Lisinopril | 240 | $1,617 | $7 |
| Diltiazem 24hr Er | 56 | $1,542 | $28 |
| Digox | 20 | $1,434 | $72 |
| Sotalol Af | 21 | $1,421 | $68 |
| Digoxin | 35 | $1,261 | $36 |
| Isosorbide Mononitrate Er | 69 | $1,180 | $17 |
| Triamterene-Hydrochlorothiazid | 103 | $1,108 | $11 |
| Doxazosin Mesylate | 48 | $1,020 | $21 |
| Losartan | 126 | $951 | $8 |
| Valsartan | 32 | $948 | $30 |
| Rosuvastatin | 17 | $942 | $55 |
| Potassium Chloride | 42 | $888 | $21 |
| Metoprolol | 143 | $857 | $6 |
| Flecainide Acetate | 11 | $792 | $72 |
| Chlorthalidone | 17 | $754 | $44 |
| Warfarin | 31 | $559 | $18 |
| Carvedilol | 76 | $546 | $7 |
| Clopidogrel | 69 | $536 | $8 |
| Valsartan-Hydrochlorothiazide | 13 | $511 | $39 |
| Nitroglycerin | 25 | $433 | $17 |
| Cartia Xt | 11 | $382 | $35 |
| Bumetanide | 15 | $375 | $25 |
| Verapamil | 17 | $348 | $20 |
| Furosemide | 65 | $315 | $5 |
| Lovastatin | 24 | $257 | $11 |
| Amiodarone | 11 | $247 | $22 |
| Cilostazol | 13 | $237 | $18 |
| Spironolactone | 33 | $219 | $7 |
| Simvastatin | 27 | $195 | $7 |
| Hydrochlorothiazide | 31 | $195 | $6 |
| Sotalol | 13 | $130 | $10 |
| Hydralazine | 11 | $127 | $12 |
| Atenolol | 26 | $104 | $4 |
| Benazepril | 16 | $100 | $6 |
2016: 46 drugs
| Eliquis | 198 | $86,749 | $438 |
| Effient | 48 | $22,075 | $460 |
| Crestor | 16 | $7,668 | $479 |
| Xarelto | 21 | $7,514 | $358 |
| Atorvastatin | 255 | $3,983 | $16 |
| Metoprolol | 167 | $3,578 | $21 |
| Isosorbide Dinitrate | 63 | $2,653 | $42 |
| Potassium Chloride | 49 | $2,548 | $52 |
| Bystolic | 16 | $1,910 | $119 |
| Lisinopril | 213 | $1,791 | $8 |
| Valsartan | 40 | $1,631 | $41 |
| Diltiazem 24hr Er | 60 | $1,518 | $25 |
| Isosorbide Mononitrate Er | 98 | $1,418 | $14 |
| Amlodipine Besylate | 233 | $1,255 | $5 |
| Losartan | 130 | $1,079 | $8 |
| Digox | 19 | $928 | $49 |
| Warfarin | 61 | $892 | $15 |
| Triamterene-Hydrochlorothiazid | 92 | $864 | $9 |
| Metoprolol | 116 | $860 | $7 |
| Nitrostat | 25 | $770 | $31 |
| Chlorthalidone | 16 | $723 | $45 |
| Digoxin | 16 | $707 | $44 |
| Clopidogrel | 52 | $584 | $11 |
| Diltiazem 24hr Cd | 13 | $536 | $41 |
| Cilostazol | 26 | $522 | $20 |
| Cartia Xt | 16 | $519 | $32 |
| Sotalol Af | 16 | $490 | $31 |
| Valsartan-Hydrochlorothiazide | 17 | $490 | $29 |
| Pravastatin | 13 | $486 | $37 |
| Carvedilol | 59 | $451 | $8 |
| Doxazosin Mesylate | 12 | $401 | $33 |
| Bumetanide | 14 | $337 | $24 |
| Furosemide | 63 | $336 | $5 |
| Hydralazine | 38 | $320 | $8 |
| Verapamil | 18 | $286 | $16 |
| Flecainide Acetate | 12 | $260 | $22 |
| Nitroglycerin | 12 | $234 | $20 |
| Amiodarone | 13 | $209 | $16 |
| Spironolactone | 25 | $202 | $8 |
| Hydrochlorothiazide | 29 | $168 | $6 |
| Atenolol | 39 | $162 | $4 |
| Simvastatin | 22 | $159 | $7 |
| Benazepril | 25 | $119 | $5 |
| Torsemide | 11 | $111 | $10 |
| Lovastatin | 11 | $97 | $9 |
| Sotalol | 14 | $69 | $5 |
2015: 42 drugs
| Eliquis | 95 | $39,938 | $420 |
| Effient | 44 | $16,744 | $381 |
| Xarelto | 33 | $11,939 | $362 |
| Ranexa | 30 | $9,167 | $306 |
| Crestor | 20 | $7,323 | $366 |
| Metoprolol | 133 | $3,711 | $28 |
| Atorvastatin | 229 | $3,659 | $16 |
| Potassium Chloride | 44 | $2,643 | $60 |
| Valsartan | 28 | $2,339 | $84 |
| Bystolic | 17 | $1,825 | $107 |
| Isosorbide Dinitrate | 32 | $1,821 | $57 |
| Amlodipine Besylate | 156 | $1,102 | $7 |
| Metoprolol | 116 | $1,100 | $9 |
| Warfarin | 62 | $1,056 | $17 |
| Digox | 12 | $975 | $81 |
| Digoxin | 20 | $951 | $48 |
| Lisinopril | 164 | $873 | $5 |
| Sotalol Af | 16 | $847 | $53 |
| Isosorbide Mononitrate Er | 78 | $829 | $11 |
| Nitrostat | 41 | $758 | $18 |
| Hydralazine | 48 | $736 | $15 |
| Cartia Xt | 18 | $728 | $40 |
| Diltiazem 24hr Er | 24 | $679 | $28 |
| Diltiazem 24hr Cd | 18 | $559 | $31 |
| Cilostazol | 18 | $527 | $29 |
| Carvedilol | 68 | $516 | $8 |
| Clopidogrel | 39 | $486 | $12 |
| Pravastatin | 15 | $458 | $31 |
| Losartan | 91 | $452 | $5 |
| Triamterene-Hydrochlorothiazid | 45 | $417 | $9 |
| Doxazosin Mesylate | 14 | $410 | $29 |
| Furosemide | 66 | $369 | $6 |
| Valsartan-Hydrochlorothiazide | 13 | $314 | $24 |
| Spironolactone | 20 | $176 | $9 |
| Simvastatin | 32 | $170 | $5 |
| Losartan-Hydrochlorothiazide | 17 | $169 | $10 |
| Sotalol | 19 | $128 | $7 |
| Diltiazem | 18 | $113 | $6 |
| Atenolol | 22 | $108 | $5 |
| Benazepril | 15 | $101 | $7 |
| Ranitidine | 13 | $75 | $6 |
| Hydrochlorothiazide | 12 | $43 | $4 |
2014: 35 drugs
| Eliquis | 47 | $19,955 | $425 |
| Xarelto | 29 | $9,948 | $343 |
| Crestor | 32 | $9,431 | $295 |
| Diovan | 28 | $7,082 | $253 |
| Ranexa | 21 | $5,554 | $264 |
| Effient | 18 | $4,814 | $267 |
| Metoprolol | 92 | $3,298 | $36 |
| Atorvastatin | 156 | $3,100 | $20 |
| Diltiazem 24hr Er | 35 | $1,582 | $45 |
| Warfarin | 90 | $1,262 | $14 |
| Clopidogrel | 82 | $1,258 | $15 |
| Amlodipine Besylate | 164 | $1,206 | $7 |
| Digoxin | 16 | $1,092 | $68 |
| Lisinopril | 176 | $1,073 | $6 |
| Carvedilol | 101 | $852 | $8 |
| Metoprolol | 137 | $788 | $6 |
| Cartia Xt | 17 | $756 | $44 |
| Digox | 16 | $754 | $47 |
| Diltiazem 24hr Cd | 19 | $678 | $36 |
| Nitrostat | 34 | $597 | $18 |
| Isosorbide Mononitrate Er | 45 | $587 | $13 |
| Cilostazol | 16 | $571 | $36 |
| Diltiazem Er | 11 | $555 | $50 |
| Losartan | 42 | $462 | $11 |
| Losartan-Hydrochlorothiazide | 31 | $420 | $14 |
| Furosemide | 80 | $334 | $4 |
| Simvastatin | 40 | $294 | $7 |
| Torsemide | 14 | $245 | $18 |
| Triamterene-Hydrochlorothiazid | 21 | $241 | $11 |
| Amiodarone | 15 | $210 | $14 |
| Benazepril | 26 | $195 | $8 |
| Sotalol | 15 | $194 | $13 |
| Spironolactone | 14 | $149 | $11 |
| Atenolol | 12 | $122 | $10 |
| Hydrochlorothiazide | 16 | $69 | $4 |
2013: 32 drugs
| Diovan | 46 | $9,847 | $214 |
| Crestor | 32 | $8,626 | $270 |
| Clopidogrel | 87 | $4,732 | $54 |
| Atorvastatin | 113 | $3,628 | $32 |
| Eliquis | 11 | $3,100 | $282 |
| Metoprolol | 94 | $2,935 | $31 |
| Diltiazem 24hr Er | 25 | $1,999 | $80 |
| Amlodipine Besylate | 130 | $1,116 | $9 |
| Warfarin | 69 | $1,081 | $16 |
| Sildenafil | 13 | $1,026 | $79 |
| Lisinopril | 131 | $982 | $7 |
| Cartia Xt | 15 | $738 | $49 |
| Carvedilol | 80 | $699 | $9 |
| Isosorbide Mononitrate Er | 37 | $662 | $18 |
| Metoprolol | 76 | $639 | $8 |
| Diltiazem 24hr Cd | 17 | $555 | $33 |
| Losartan-Hydrochlorothiazide | 23 | $477 | $21 |
| Simvastatin | 56 | $449 | $8 |
| Nitrostat | 31 | $437 | $14 |
| Triamterene-Hctz | 33 | $427 | $13 |
| Cilostazol | 16 | $412 | $26 |
| Spironolactone | 41 | $347 | $8 |
| Furosemide | 65 | $286 | $4 |
| Amiodarone | 26 | $245 | $9 |
| Atenolol | 27 | $241 | $9 |
| Klor-Con 8 | 14 | $205 | $15 |
| Losartan | 15 | $185 | $12 |
| Benazepril | 19 | $169 | $9 |
| Digox | 19 | $142 | $7 |
| Digoxin | 16 | $106 | $7 |
| Hydrochlorothiazide | 13 | $67 | $5 |
| Sotalol | 19 | $38 | $2 |
Money from drug and device companies
$193 in 2025
| 2025 | 2 | 2 | None | $193 |
| 2024 | 1 | 1 | None | $199 |
| 2022 | 3 | 3 | None | $231 |
| 2021 | 1 | 1 | None | $100 |
| 2020 | 1 | 1 | None | $15 |
| 2019 | 2 | 2 | None | $232 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Biotronik | Solia | $167 | 1 payment
|
| Abbott Laboratories | Triclip | $26 | 1 payment
|
See all 2 published payments
| Abbott Laboratories | Meals · 2025-10-28 | Triclip | $26 |
| Biotronik | Meals · 2025-09-18 | Solia | $167 |
See earlier years (2024, 2022, 2021, 2020, 2019)
2024: $199
| ShockWave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $199 | 1 payment
|
2022: $231
| Biotronik | Biomonitor | $159 | 1 payment
|
| Boston Scientific | Synergy | $50 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $22 | 1 payment
|
2021: $100
| AstraZeneca Pharmaceuticals LP | Brilinta | $100 | 1 payment
|
2020: $15
| Bardy Diagnostics | Carnation Ambulatory Monitor | $15 | 1 payment
|
2019: $232
| Abiomed | Impella | $125 | 1 payment
|
| Boston Scientific | Stingray | $107 | 1 payment
|
Checkups this office reported
8 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 93.3 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Advance care plan on fileOlder patients with an advance care plan or a documented conversation about one | 100%That's most of the people this applied to. | 424 |
| Blood pressure under controlPeople with high blood pressure whose reading was in a healthy range | 83%That's most of the people this applied to. | 157 |
| Medications listed in the chartVisits where the current medication list was documented | 100%That's most of the people this applied to. | 1,344 |
| Patients can see their records onlinePatients who were given electronic access to their health information | 100%That's most of the people this applied to. | 276 |
| Prescriptions sent electronicallyPrescriptions sent to the pharmacy by computer instead of paper | 99%That's most of the people this applied to. | 478 |
| Risky medications in older adultsOlder patients given a medication that is risky at their age | 0%That's few of the people this applied to. Better on this measure. | 428 |
| Screening for High Blood Pressure and Follow-Up DocumentedAs Medicare defines this measure | 19% | 1,344 |
| Weight checked, with a follow-up planPatients whose BMI was recorded and followed up if needed | 99%That's most of the people this applied to. | 687 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Agreed to federal review of their records system
- Did a security review of patient data
- Implementation of improvements that contribute to more timely communication of test results
- Implementation of medication management practice improvements
- ONC-ACB Surveillance Attestation
- Exempt from electronic case reporting
- Exempt from immunization registry reporting
- Exempt from query of the prescription drug monitoring program (pdmp)
- Exempt from support electronic referral loops by receiving and reconciling health information
- Exempt from support electronic referral loops by sending health information
Professional record
- NPI
- 1891783437
- Licence
- CA A 70992California A70992: Current · expires 2027-11-30
- Trained
- University of Southern California Keck School of Medicine, 1998
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Cardiology (207RC0000X); Federal specialty code 207RI0011X (207RI0011X)
- Mailing address
- 2242 Camden Ave Ste 201, San Jose, CA, 95124
- NPI first listed
- 2005-10-07
- NPI last updated
- 2024-07-23
- NPI record certified
- 2024-07-23
This is when the NPI record was last certified, not a medical board exam.